Literature DB >> 14190487

STUDIES ON TYROSINOSIS: 1, EFFECT OF LOW-TYROSINE AND LOW-PHENYLALANINE DIET.

S HALVORSEN, L R GJESSING.   

Abstract

Entities:  

Keywords:  ACETATES; AMINO ACID METABOLISM; AMINOACIDURIA, RENAL; BLOOD PHOSPHATES; CHILD; DIET THERAPY; HEPATOMEGALY; KIDNEY FUNCTION TESTS; LACTATES; LIVER DISEASES; LIVER FUNCTION TESTS; PHENYLALANINE; PHENYLPYRUVIC ACID; RICKETS; TYROSINE; URINE

Mesh：

Substances：

Year:  1964        PMID： 14190487      PMCID： PMC1816734          DOI： 10.1136/bmj.2.5418.1171

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  TYROSINOSIS.

Authors:  R ZETTERSTROEM
Journal:  Ann N Y Acad Sci       Date:  1963-12-30       Impact factor: 5.691

2.  FAMILIAL CIRRHOSIS OF THE LIVER, RENAL TUBULAR DEFECTS WITH RICKETS AND IMPAIRED TYROSINE METABOLISM.

Authors:  S FRITZELL; O R JAGENBURG; L B SCHNUERER
Journal:  Acta Paediatr       Date:  1964-01       Impact factor: 2.299

3.  Use of micromethod for phenylalanine in management of phenylketonuric patients.

Authors:  H K BERRY
Journal:  Clin Chem       Date:  1962-04       Impact factor: 8.327

4.  The phenolic acids of human urine; paper chromatography of phenolic acids.

Authors:  M D ARMSTRONG; K N SHAW; P E WALL
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

5.  Changing diagnostic criteria for hyperparathyroidism.

Authors:  L GOLDMAN; G S GORDAN; E L CHAMBERS
Journal:  Ann Surg       Date:  1957-09       Impact factor: 12.969

6.  A new error of tyrosine metabolism: tyrosinosis. The intermediary metabolism of tyrosine and phenylalanine.

Authors:  G Medes
Journal:  Biochem J       Date:  1932       Impact factor: 3.857

7.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

Authors:  P A OWREN; K AAS
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713
  7 in total
  9 in total

1.  Type I hereditary tyrosinaemia: presentation of 11 cases.

Authors:  T Coşkun; I Ozalp; N Koçak; A Yüce; M Caglar; R Berger
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.

Authors:  Víctor R De Jesús; Barbara W Adam; Daniel Mandel; Carla D Cuthbert; Dietrich Matern
Journal:  Mol Genet Metab       Date:  2014-07-17       Impact factor: 4.797

Review 3.  Diseases of Jews.

Authors:  D M Krikler
Journal:  Postgrad Med J       Date:  1970-12       Impact factor: 2.401

4.  Urinary screening tests in the prevention of mental deficiency.

Authors:  T L Perry; S Hansen; L MacDougall
Journal:  Can Med Assoc J       Date:  1966-07-16       Impact factor: 8.262

5.  Tyrosinosis. A study of 6 cases.

Authors:  S Halvorsen; H Pande; A C Loken; L R Gjessing
Journal:  Arch Dis Child       Date:  1966-06       Impact factor: 3.791

6.  Genetic aspects of tyrosinemia in the Chicoutimi region.

Authors:  C Laberge; L Dallaire
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

7.  Tyrosinosis (inborn hepato-renal dysfunction).

Authors:  L I Woolf
Journal:  Proc R Soc Med       Date:  1966-09

8.  Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.

Authors:  S Manabe; S Sassa; A Kappas
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

Review 9.  Hepatorenal tyrosinemia.

Authors:  Teruo Kitagawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.